GLMD icon

Galmed Pharmaceuticals

20 hedge funds and large institutions have $19.3M invested in Galmed Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
20
Holders Change
+20
Holders Change %
% of All Funds
0.58%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
20
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
DCM
1
DAFNA Capital Management
California
$2.32M 202,100 +202,100 New
PWAM
2
Park West Asset Management
California
$2.29M 200,000 +200,000 New
SFM
3
Sphera Funds Management
Israel
$1.95M 170,000 +170,000 New
6CM
4
683 Capital Management
New York
$1.82M 158,735 +158,735 New
VAM
5
Visium Asset Management
New York
$1.78M 154,773 +154,773 New
Lord, Abbett & Co
6
Lord, Abbett & Co
New Jersey
$1.65M 143,600 +143,600 New
HCMT
7
Highland Capital Management (Texas)
Texas
$1.46M 126,956 +126,956 New
GPCM
8
Granite Point Capital Management
Massachusetts
$1.32M 115,000 +115,000 New
PA
9
Perceptive Advisors
New York
$860K 75,000 +75,000 New
HM
10
HealthCor Management
New York
$814K 71,000 +71,000 New
KCM
11
Knoll Capital Management
Florida
$746K 65,000 +65,000 New
GF
12
Gerry Farber
New York
$596K 52,000 +52,000 New
HVC
13
Healthcare Value Capital
New Jersey
$574K 50,000 +50,000 New
SM
14
Sabby Management
Florida
$360K 31,401 +31,401 New
SKK
15
Shepherd Kaplan Krochuk
Massachusetts
$297K 25,886 +25,886 New
Deutsche Bank
16
Deutsche Bank
Germany
$229K 20,000 +20,000 New
SCM
17
Sterling Capital Management
North Carolina
$125K 10,929 +10,929 New
Morgan Stanley
18
Morgan Stanley
New York
$38K 3,317 +3,317 New
U
19
UBS
Switzerland
$23K 2,000 +2,000 New
TRCT
20
Tower Research Capital (TRC)
New York
$15K 1,283 +1,283 New